ArticleBiotechnology and bioengineering2025
Gold Nanoparticles Coated With Hydrophobin-ProteinA Fusion Protein: Development of a Versatile Immunosensing Platform.
Article in Biotechnology and bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Heterologous expression and interfacial activity evaluation of Pleurotus ostreatus hydrophobin Vmh2 mutants in Tremella fuciformis.World journal of microbiology & biotechnology · 2026Article
- Gold Nanoparticles Coated With Hydrophobin-ProteinA Fusion Protein: Development of a Versatile Immunosensing Platform.Biotechnology and bioengineering · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Advancing immunosensing technologies hinges on the development of next-generation surface functionalization methods, as the precise anchoring of antibodies on transducer interface is essential for achieving high sensitivity and selectivity. Among the diverse methodologies explored, bioengineered materials have shown significant potential to improve antibody orientation, stability, and functional performance. In this study, we present a chimeric protein created by fusing the adhesive Class I hydrophobin Vmh2 from Pleurotus ostreatus, with the Fc-binding region of protein A from Staphylococcus aureus (SpA). This fusion protein spontaneously adheres on gold nanoparticles (AuNPs) without requiring chemical modification, forming a robust bio-interactive layer for antibody attachment. The platform's adaptability and effectiveness were assessed using an immunoglobulin specific to a fungal laccase to establish the performance of the system, and antibodies against two clinically significant targets- mesothelin, a tumor-associated glycoprotein, and the SARS-CoV-2 spike protein- to showcase the diagnostic potential of the system. A two-step method based on the induced aggregation of the AuNps not bound to the analyte allows underscoring the platform's promise in biosensing applications. Overall, this approach represents a sustainable, versatile, and low-cost route for fabricating biologically active surfaces, with wide-ranging relevance in medical diagnostics, environmental analysis, and biotechnological innovation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.